SCHEMBL15780784

SCHEMBL15780784

CC(=O)/C=C/c1ccc(O)c(C(N)=O)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS1 P23219 2/20 0.67
▸ IAPP P10997 2/20 0.67
▸ APP P05067 3/20 0.58
▸ PTPN1 P18031 4/20 0.50
▸ PTPN2 P17706 1/20 0.50
▸ PTPN6 P29350 1/20 0.50
▸ KDM4E B2RXH2 3/20 0.46
▸ PTGS2 P35354 3/20 0.46
▸ GAA P10253 2/20 0.46
▸ MAPT P10636 2/20 0.46
▸ MAPK1 P28482 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46
▸ MYOC Q99972 1/20 0.46
▸ HNF4A P41235 1/20 0.46
▸ HSD17B10 Q99714 2/20 0.46
▸ GLA P06280 2/20 0.46
▸ TDP1 Q9NUW8 2/20 0.46
▸ TTR P02766 2/20 0.46
▸ MEN1 O00255 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15780776 0.87 IAPP (0.67) PTGS1IAPPAPPPTPN1KDM4E
SCHEMBL17365408 0.86 PTGS1 (0.71) PTGS1IAPPAPPPTPN1PTPN2
SCHEMBL14898191 0.85 KDM4E (0.66) PTGS1IAPPAPPPTPN1PTPN2
SCHEMBL1881133 0.80 IAPP (1.00) PTGS1IAPPAPPPTPN1KDM4E
SCHEMBL29364807 0.80 IAPP (1.00) PTGS1IAPPAPPPTPN1KDM4E
SCHEMBL1881134 0.80 IAPP (1.00) PTGS1IAPPAPPPTPN1KDM4E
SCHEMBL19729146 0.79 IAPP (0.71) PTGS1IAPPAPPPTPN1KDM4E
SCHEMBL1603718 0.79 PTPN1 (0.62) APPPTPN1PTPN2PTPN6KDM4E
SCHEMBL1603721 0.79 PTPN1 (0.62) APPPTPN1PTPN2PTPN6KDM4E
SCHEMBL6173521 0.79 TTR (0.72) APPTTRCA12AKR1B10CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140194383-A1 MONOMERS CAPABLE OF DIMERIZING IN AN AQUEOUS SOLUTION, AND METHODS OF USING SAME CORNELL UNIVERSITY (US) 2014-07-10 — — US disclosed
US-20140161729-A1 COFLUORONS AND METHODS OF MAKING AND USING THEM CORNELL UNIVERSITY (US) 2014-06-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140161729-A1 COFLUORONS AND METHODS OF MAKING AND USING THEM TNFSF11, CD14, TNFRSF1A PTGS1 4008/4885IAPP 1783/4885APP 674/4885
US-20140194383-A1 MONOMERS CAPABLE OF DIMERIZING IN AN AQUEOUS SOLUTION, AND METHODS OF USING SAME CALCOCO2, MDN1, MBNL1 PTGS1 3089/4885IAPP 1331/4885APP 848/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback